DPP4 and fatty liver disease: Of note, the overall improvement in hepatic steatosis is also found in patients treated with other classes of anti-diabetic drugs, like thiazolidinediones and dipeptidyl peptidase-4 (DPP-4) inhibitors, raising the question of steatosis improvement due to glycemic control [148,160,162,170].